Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo
- 28 July 2009
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (30), 12424-12429
- https://doi.org/10.1073/pnas.0905409106
Abstract
Anthrax toxin, a major virulence factor of Bacillus anthracis, gains entry into target cells by binding to either of 2 von Willebrand factor A domain-containing proteins, tumor endothelium marker-8 (TEM8) and capillary morphogenesis protein-2 (CMG2). The wide tissue expression of TEM8 and CMG2 suggest that both receptors could play a role in anthrax pathogenesis. To explore the roles of TEM8 and CMG2 in normal physiology, as well as in anthrax pathogenesis, we generated TEM8- and CMG2-null mice and TEM8/CMG2 double-null mice by deleting TEM8 and CMG2 transmembrane domains. TEM8 and CMG2 were found to be dispensable for mouse development and life, but both are essential in female reproduction in mice. We found that the lethality of anthrax toxin for mice is mostly mediated by CMG2 and that TEM8 plays only a minor role. This is likely because anthrax toxin has approximately 11-fold higher affinity for CMG2 than for TEM8. Finally, the CMG2-null mice are also shown to be highly resistant to B. anthracis spore infection, attesting to the importance of both anthrax toxin and CMG2 in anthrax infections.Keywords
This publication has 37 references indexed in Scilit:
- Functional interactions between anthrax toxin receptors and the WNT signalling protein LRP6Cellular Microbiology, 2008
- Characterization of the interaction between anthrax toxin and its cellular receptorsCellular Microbiology, 2006
- Anthrax Toxin Receptor 2–Dependent Lethal Toxin Killing In VivoPLoS Pathogens, 2006
- Genome Engineering in Bacillus anthracis Using Cre RecombinaseInfection and Immunity, 2006
- Late Treatment with a Protective Antigen–Directed Monoclonal Antibody Improves Hemodynamic Function and Survival in a Lethal Toxin–Infused Rat Model of Anthrax SepsisThe Journal of Infectious Diseases, 2005
- Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- Mutations in the Gene Encoding Capillary Morphogenesis Protein 2 Cause Juvenile Hyaline Fibromatosis and Infantile Systemic HyalinosisAmerican Journal of Human Genetics, 2003
- Alanine-scanning Mutations in Domain 4 of Anthrax Toxin Protective Antigen Reveal Residues Important for Binding to the Cellular Receptor and to a Neutralizing Monoclonal AntibodyJournal of Biological Chemistry, 2003
- Anthrax toxin: structures, functions and tumour targetingExpert Opinion on Biological Therapy, 2003
- Anthrax Lethal Factor Cleaves the N-Terminus of MAPKKs and Induces Tyrosine/Threonine Phosphorylation of MAPKs in Cultured MacrophagesBiochemical and Biophysical Research Communications, 1998